K252a

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

<templatestyles src="Chembox/styles.css"/>

Template:Chembox image cellTemplate:Chembox image cellTemplate:Chembox AllOtherNamesTemplate:Chembox headerbarTemplate:Chembox IndexlistTemplate:Chembox JmolTemplate:Chembox ChEMBLTemplate:Chembox ECHATemplate:Chembox E numberTemplate:Chembox IUPHAR ligandTemplate:Chembox UNIITemplate:Chembox CompToxTemplate:Chembox headerbarTemplate:Chembox Datapage checkTemplate:Chembox Footer
K252a
Template:Longitem Template:Unbulleted list
ChEBI Template:Unbulleted list
ChemSpider Template:Unbulleted list
DrugBank Template:Unbulleted list
EC Number Template:Unbulleted list
KEGG Template:Unbulleted list
Template:Longitem Template:Unbulleted list
RTECS number Template:Unbulleted list
Script error: No such module "collapsible list".
Template:Longitem Template:Chembox Elements/molecular formula
Molar mass Template:Chem molar mass
Solubility in other solvents Soluble in DMSO, dichloromethane, and methanol

Template:Chembox Footer/trackingScript error: No such module "TemplatePar".Template:Short description

K252a is an alkaloid isolated from Nocardiopsis bacteria. This staurosporine analog is a highly potent cell permeable inhibitor of CaM kinase and phosphorylase kinase (IC50 = 1.8 and 1.7 nmol/L, respectively). At higher concentrations it is also an efficient inhibitor of serine/threonine protein kinases (IC50 of 10 to 30 nmol/L).[1][2][3][4][5][6][7][8]

K252a is reported to promote myogenic differentiation in C2 mouse myoblasts[5] and has been shown to block the neuronal differentiation of rat pheochromocytoma PC12 cells by inhibition of trk tyrosine kinase activity.[9]

K252a has been reported in preclinical research as a potential treatment for psoriasis.[10]

K252a inhibits tyrosine phosphorylation of Trk A induced by NGF. PC12 cells were incubated in the presence or absence of 10 ng/ml NGF with or without various concentrations of K252a.

See also

References

<templatestyles src="Reflist/styles.css" />

  1. ↑ Ruegg, U.T. et al. (1989) Tips 10, 218.
  2. ↑ Eliot, L.H. et al. (1990) B.B.R.C. 171, 148.
  3. ↑ Simpson, D.l. et al. (1991) J. Neurosci. Res, 28, 148.
  4. ↑ Chin, L.S. et al. (1999) Cancer Invest. 17, 391.
  5. ↑ a b Tapley, P. et al. (1992) Oncogene 7, 371.
  6. ↑ Hashimoto, S. (1998) J. Cell Biol. 107, 1531.
  7. ↑ Kase, H. et al. (1987) B.B.R.C. 142, 436.
  8. ↑ Hirayama E. et al. (2001) B.B.R.C. 285, 1237.
  9. ↑ Borasio, G.D. Neurosci. Lett. (1990) 108, 207.
  10. ↑ Script error: No such module "Citation/CS1".

Script error: No such module "Check for unknown parameters".

Further reading

  • Script error: No such module "Citation/CS1".

Template:Growth factor receptor modulators